课题基金 / 基金详情

Phenotypic and functional characterization of primary human lymphoid dendritic cells, with a focus on XCR1+ DC

Phenotypic and functional characterization of primary human lymphoid dendritic cells, with a focus on XCR1+ DC
原代人淋巴树突状细胞的表型和功能特征,重点是 XCR1 DC
批准号:
202056988
负责人:
Professor Dr. Richard Kroczek
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2015-12-31

项目摘要

项目成果

Professor Dr. Richard Kroczek的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Dendritic cells (DC) are cells in the immune system, which “professionally” take up protein antigens and present it to T cells. The ensuing “dialogue” between T cells and DC is pivotal for the decision between “immunity” and “tolerance” to an antigen. While important advances have been made in the understanding of DC subset function in the mouse, information on primary human conventional DC remained surprisingly scarce, apparently because of their very low numbers in blood and lymphoid tissues and the lack of markers. Instead, almost all experiments in the human have been performed with DC generated from monocytes in vitro, cells which only incompletely reflect primary DC. Very recently, we characterized a subset-specific DC surface molecule (XCR1 receptor), additional molecules on DC were defined by others. These advances, together with improved cell isolation techniques, allow now to better characterize primary human DC. In the project, we intend to refine the current initial understanding of primary human blood DC for antigen (cross-) presentation to T cells and to define the basic phenotype and immune function of human DC resident in lymphoid tissues and peripheral organs. This information will show whether the concepts developed in the mouse also hold true for human DC in health and (autoimmune) disease. The gained knowledge is a prerequisite for the future development of novel vaccines by us and others, in which cytotoxic immunity to tumors and intracellular pathogens is to be achieved by direct targeting of antigen to XCR1+ DC in vivo.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4049/jimmunol.1401903
发表时间: 2015-02-01
期刊: JOURNAL OF IMMUNOLOGY
影响因子: 4.4
作者: [Hartung, Evelyn, Becker, Martina, Kroczek, Richard A.]
通讯作者: Kroczek, Richard A.
Role of CD8+ dendritic cells in antigen (cross-) presentation and cytotoxic immunity of the mouse and the human
Klonierung, biochemische und funktionelle Charakterisierung eines neuen, T-Zell-spezifischen Zelloberflächenmoleküls (8F4)
Regulation, Expression und Effektorfunktion des TRAP (CD40L)-Moleküls unter physiologischen und pathologischen Bedingungen
国内基金
海外基金
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
  • 批准号:
    82371373
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    沃雁
  • 依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    陶永
  • 依托单位:
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
  • 批准号:
    82371873
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    乔洁
  • 依托单位: